We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ranbaxy Can't Dodge Lupin's Suit Over Generic Antara

Law360 (April 21, 2011, 7:52 PM EDT) -- A Pennsylvania federal judge on Thursday rejected Ranbaxy Laboratories Ltd.'s bid to nix a Lupin Ltd. unit's lawsuit seeking to block Ranbaxy from launching a generic version of the cholesterol drug Antara.

Judge Gene E. K. Pratter of the Eastern District of Pennsylvania denied Ranbaxy's motion to dismiss one of three lawsuits Lupin Atlantis Holdings SA has lodged accusing the generic-drug maker of infringing the patent that covers Antara with its proposed generic drug.

Ranbaxy's motion asked the court to dismiss the lawsuit because it is...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.